Reasons Charcot-Marie-Tooth disease due to mutations in the MME gene should not be named AR-CMT2T.

Stéphane Mathis, Cyril Goizet, Meriem Tazir, Laurent Magy, Jean‐Michel Vallat
Ann Neurol.. 2016-08-04; 80(3): 477-477
DOI: 10.1002/ana.24741

PubMed
Lire sur PubMed



1. Ann Neurol. 2016 Sep;80(3):477. doi: 10.1002/ana.24741. Epub 2016 Aug 4.

Reasons Charcot-Marie-Tooth disease due to mutations in the MME gene should not
be named AR-CMT2T.

Mathis S(1), Goizet C(2), Tazir M(3), Magy L(4), Vallat JM(4).

Author information:
(1)Department of Neurology, Poitiers University Hospital Center, Poitiers,
France.
(2)Department of Medical Genetics, (national reference center « Neuromuscular
Diseases of the Great Southwest »), University Hospital (Pellegrin University
Hospital Center), and Maladies Rares: Génétique et Métabolisme (MRGM) Laboratory,
National Institute of Health and Medical Research U1211, University of Bordeaux,
Bordeaux, France.
(3)Department of Neurology, Mustapha Bacha University Hospital, Algiers, Algeria.
(4)Department of Neurology, (National reference center « Rare Peripheral
Neuropathies »), Dupuytren University Hospital, Limoges, France.

Comment in
Ann Neurol. 2016 Sep;80(3):477-8.

Comment on
Ann Neurol. 2016 Apr;79(4):659-72.

DOI: 10.1002/ana.24741
PMID: 27458975 [Indexed for MEDLINE]

Auteurs Bordeaux Neurocampus